147 related articles for article (PubMed ID: 32474144)
21. Anticoagulation in Patients with Premature Peripheral Artery Disease Undergoing Lower Extremity Revascularization.
Kim TI; DeWan A; Murray M; Wang H; Mani A; Mena-Hurtado C; Guzman RJ; Ochoa Chaar CI
Ann Vasc Surg; 2024 Aug; 105():150-157. PubMed ID: 38593922
[TBL] [Abstract][Full Text] [Related]
22. Perioperative outcomes of infrainguinal bypass surgery in patients with and without prior revascularization.
Bodewes TCF; Ultee KHJ; Soden PA; Zettervall SL; Shean KE; Jones DW; Moll FL; Schermerhorn ML
J Vasc Surg; 2017 May; 65(5):1354-1365.e2. PubMed ID: 28190717
[TBL] [Abstract][Full Text] [Related]
23. Use of angiotensin-converting enzyme inhibitors and freedom from amputation after lower extremity revascularization.
Kray JE; Dombrovskiy VY; Vogel TR
Vasc Health Risk Manag; 2017; 13():269-274. PubMed ID: 28761352
[TBL] [Abstract][Full Text] [Related]
24. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S
J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113
[TBL] [Abstract][Full Text] [Related]
25. One-Year Readmission after Open and Endovascular Revascularization for Critical Limb Ischemia.
Ochoa Chaar CI; Gholitabar N; Goodney P; Dardik A; Abougergi MS
Ann Vasc Surg; 2019 Nov; 61():25-32.e2. PubMed ID: 31376536
[TBL] [Abstract][Full Text] [Related]
26. Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.
Desai K; Han B; Kuziez L; Yan Y; Zayed MA
J Vasc Surg; 2021 Feb; 73(2):711-721.e3. PubMed ID: 32891809
[TBL] [Abstract][Full Text] [Related]
27. Reinterventions after Endovascular Revascularization in Elderly Patients with Critical Limb Ischemia: An Observational Study.
Klaphake S; de Leur K; Thijsse W; Ho GH; de Groot HGW; Veen EJ; Haans DHAW; van der Laan L
Ann Vasc Surg; 2018 Nov; 53():171-176. PubMed ID: 29886205
[TBL] [Abstract][Full Text] [Related]
28. Bypass versus endovascular intervention for healing ischemic foot wounds secondary to tibial arterial disease.
Mohapatra A; Henry JC; Avgerinos ED; Boitet A; Chaer RA; Makaroun MS; Leers SA; Hager ES
J Vasc Surg; 2018 Jul; 68(1):168-175. PubMed ID: 29336904
[TBL] [Abstract][Full Text] [Related]
29. Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease.
Bodewes TCF; Darling JD; Deery SE; O'Donnell TFX; Pothof AB; Shean KE; Moll FL; Schermerhorn ML
J Vasc Surg; 2018 Jan; 67(1):206-216.e2. PubMed ID: 28844467
[TBL] [Abstract][Full Text] [Related]
30. Comparison of open and endovascular procedures in patients with critical limb ischemia on dialysis.
Ramanan B; Jeon-Slaughter H; Chen X; Modrall JG; Tsai S
J Vasc Surg; 2019 Oct; 70(4):1217-1224. PubMed ID: 30922740
[TBL] [Abstract][Full Text] [Related]
31. Neutrophil-lymphocyte ratio predicts disease severity and outcome after lower extremity procedures.
Bath J; Smith JB; Kruse RL; Vogel TR
J Vasc Surg; 2020 Aug; 72(2):622-631. PubMed ID: 31882318
[TBL] [Abstract][Full Text] [Related]
32. Outcomes after Lower Extremity Revascularization for Treatment of Critical Limb Ischemia with Tissue Loss in Patients with Chronic Immune-Mediated Inflammatory Disease.
O'Brien-Irr MS; Dryjski ML; Dosluoglu HH; Shalaby S; Cherr G; Rivero M; Kuoduomas D; Harris LM
Ann Vasc Surg; 2019 Feb; 55():96-103. PubMed ID: 30217708
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID Trial.
Baumgartner I; Norgren L; Fowkes FGR; Mulder H; Patel MR; Berger JS; Jones WS; Rockhold FW; Katona BG; Mahaffey K; Hiatt WR;
J Am Coll Cardiol; 2018 Oct; 72(14):1563-1572. PubMed ID: 30261955
[TBL] [Abstract][Full Text] [Related]
34. The Impact of Clinical Follow-Up After Revascularization on the Outcomes of Patients with Chronic Limb Threatening Ischemia.
Kiwan G; Mohamedali A; Kim T; Zhuo H; Zhang Y; Mena-Hurtado C; Mojibian H; Cardella J; Ochoa Chaar CI
Ann Vasc Surg; 2022 Oct; 86():286-294. PubMed ID: 35803459
[TBL] [Abstract][Full Text] [Related]
35. Variations in the Management of Claudication in a Tertiary Care Center.
Ochoa Chaar CI; Gholitabar N; Detrani M; Jorshery SD; Kim TI; Zhuo H; Zhang Y; Dardik A
Ann Vasc Surg; 2020 Aug; 67():395-402. PubMed ID: 32179142
[TBL] [Abstract][Full Text] [Related]
36. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
Darling JD; McCallum JC; Soden PA; Korepta L; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
J Vasc Surg; 2017 Aug; 66(2):466-475. PubMed ID: 28274753
[TBL] [Abstract][Full Text] [Related]
37. Clopidogrel and 1-year freedom from amputation after endovascular lower extremity revascularization in the Medicare population.
Janzen ML; Dombrovskiy VY; Galiñanes EL; Vogel TR
Vasc Endovascular Surg; 2014; 48(7-8):509-15. PubMed ID: 25487246
[TBL] [Abstract][Full Text] [Related]
38. Vascular surgery trends in Australia: 2001-2015: less open surgery, less limb loss and more endovascular intervention.
Wright MA; Steffens D; Huilgol RL
ANZ J Surg; 2019 Apr; 89(4):309-313. PubMed ID: 30321911
[TBL] [Abstract][Full Text] [Related]
39. Improving 1-Year Outcomes of Infrainguinal Limb Revascularization: Population-Based Cohort Study of 104 000 Patients in England.
Heikkila K; Mitchell DC; Loftus IM; Johal AS; Waton S; Cromwell DA
Circulation; 2018 May; 137(18):1921-1933. PubMed ID: 29317447
[TBL] [Abstract][Full Text] [Related]
40. Contemporary Endovascular 30-Day Outcomes for Critical Limb Threatening Ischemia Relative to Surgical Bypass Grafting.
Latz CA; Boitano L; Wang LJ; Pendleton AA; DeCarlo C; Sumpio B; Schwartz S; Srivastava S; Dua A
Vasc Endovascular Surg; 2021 Jul; 55(5):441-447. PubMed ID: 33602047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]